The EMBO Journal Vol.17 No.9 pp.2494–2503, 1998
TRAPP, a highly conserved novel complex on the
cis-Golgi that mediates vesicle docking and fusion
Michael Sacher, Yu Jiang1,
Jemima Barrowman, Al Scarpa,
Judy Burston, Li Zhang, David Schieltz2,
John R.Yates III2, Hagai Abeliovich and
Susan Ferro-Novick3
Howard Hughes Medical Institute and the Department of Cell Biology,
Yale University School of Medicine, New Haven, CT 06510 and
2Department of Molecular Biotechnology, University of Washington,
Seattle, WA 98195-7730, USA
1Present address: Department of Molecular Biology, Princeton
University, Washington Road, Princeton, NJ 08544, USA
3Corresponding author
e-mail: susan_ferronovick@qm.yale.edu
We previously identified BET3 by its genetic interactions with BET1, a gene whose SNARE-like product
acts in endoplasmic reticulum (ER)-to-Golgi transport.
To gain insight into the function of Bet3p, we added
three c-myc tags to its C-terminus and immunopurified
this protein from a clarified detergent extract. Here
we report that Bet3p is a member of a large complex
(~800 kDa) that we call TRAPP (transport protein
particle). We propose that TRAPP plays a key role in
the targeting and/or fusion of ER-to-Golgi transport
vesicles with their acceptor compartment. The localization of Bet3p to the cis-Golgi complex, as well as
biochemical studies showing that Bet3p functions on
this compartment, support this hypothesis. TRAPP
contains at least nine other constituents, five of which
have been identified and shown to be highly conserved
novel proteins.
Keywords: membrane traffic/novel complex/vesicle
targeting and fusion
In yeast, analogs of NSF and α-SNAP are encoded by
the SEC18 (Wilson et al., 1989) and SEC17 genes (Griff
et al., 1992), respectively, while SNAREs on the vesicle
and target membrane (t-SNAREs) can be found at every
stage of the pathway. Using the yeast Saccharomyces
cerevisiae as a model system, we have been studying the
mechanism by which endoplasmic reticulum (ER)-derived
transport vesicles target and fuse with the Golgi apparatus.
In ER-to-Golgi transport, the v-SNAREs, Bos1p and
Sec22p (Lian et al., 1994), bind to a domain on Sed5p
(Sacher et al., 1997) that is homologous to syntaxin
(Hardwick and Pelham, 1992). These v/t-SNARE interactions are potentiated by a third SNARE, Bet1p, that
contains a domain which is homologous to SNAP-25
(Stone et al., 1997). The small GTP-binding protein Ypt1p
(Rab1 in mammalian cells) acts upstream of these events
(Dascher et al., 1991; Lian et al., 1994; Søgaard et al.,
1994).
BET3 encodes a 22 kDa hydrophilic protein that previously was identified in a synthetic lethal screen with the
bet1-1 mutant (Rossi et al., 1995). While Bet3p interacts
genetically with SNAREs, this gene product is not part
of the SNARE complex that forms at 37°C in sec18
mutant cells (Rossi et al., 1995). Here we show that Bet3p
is a component of a large complex, called TRAPP, which
is highly conserved from yeast to man. This complex
includes Bet5p, identified as a high-copy suppressor of
the temperature-sensitive bet3-1 mutant (Jiang et al.,
1998), and at least nine other proteins. TRAPP resides on
the cis-Golgi complex where it acts prior to SNARE
complex assembly.
Results
Introduction
The secretory pathway is highly conserved from yeast to
man (Ferro-Novick and Jahn, 1994). In the neuron, the
synaptic vesicle protein synaptobrevin and the plasma
membrane proteins syntaxin and SNAP-25 are key players
in the docking and fusion of vesicles with their acceptor
membrane (Söllner et al., 1993a). These proteins, called
SNAREs, interact with each other to form a stable ternary
complex that subsequently binds the soluble factors NSF
and α-SNAP (Söllner et al., 1993b). NSF then mediates
the disassembly of this complex in conjunction with
membrane fusion (Söllner et al., 1993a), or post-fusion to
re-activate the SNAREs for a new round of transport
(Mayer et al., 1996). The recent finding that a v-SNARE
(vesicle SNARE) can function in two different membrane
traffic events (Fischer von Mollard et al., 1997) suggests
that the SNAREs cannot be the sole determinants of
vesicle targeting.
2494
Bet3p is a component of a large complex
To begin to address the function of Bet3p, we added three
c-myc tags to the C-terminus of this protein and then
precipitated the associated proteins from a radiolabeled
lysate with anti-c-myc antibody. Figure 1A demonstrates
that in addition to Bet3p (~27 kDa with three c-myc tags),
nine radiolabeled bands were specifically precipitated.
These bands were only precipitated from a lysate that
contained tagged Bet3p (compare lane 2 with lane 1 in
Figure 1A), and co-purified during size exclusion and
ion exchange chromatography (Figure 1B). The Bet3passociated proteins included several low molecular weight
polypeptides (18, 20, 23 and 33 kDa) and a 31 kDa
species (see starred band below p33 in Figure 1B) that
was not well resolved from the 33 kDa polypeptide. In
addition, five high molecular weight bands (65, 85, 105,
120 and 130 kDa) were present. We determined, from gel
filtration analysis, that none of the cellular Bet3p was
monomeric, but instead was present with the radiolabeled
© Oxford University Press
Novel complex in ER-to-Golgi transport
Table I. Peptides identified by mass spectrometry of TRAPP subunits
Subunit
Sequence
name
p20
YBR254c
p23
p33
Peptides identified
(K)DNPVYEIEFTNAENPQGFPQDLK
(K)KDNPVYEIEFTNAENPQGFPQDLK
(M)PQYFAIIGK
(R)SFYQEVHELYVK
YDR246w (M)AIETILVINK
(K)ALQLTQQTNIENTIPYIPYVGMSSNR
(K)LNSNEYLILASTLHGVFAIASQLTPK
(K)SGGLIYQR
(R)SNLFDEK
YOR115c (R)AQQQYQIFENSLPK
(R)GTFYLLDYDYRPIQSFSLEEDAK
(R)GTFYLLDYDYRPIQSFSLEEDAKNEELK
(K)IEEHHTVDIIR
(K)LSELLIFSNNPNLK
(K)MIEPFLEIPVGIIR
(R)QISGDVISSDSNVTSENGNINNMIKR
(R)SHNLIHELYK
(R)SHNLIHELYKADEEEKEK
(K)VSQSVYQMLLNEMVPLAMGIER
Fig. 1. Bet3p is a component of a large complex. (A) Lane 1, wildtype (with no tag, SFNY 26-6A) and lane 2, SFNY656 (c-myc-tagged
Bet3p) were labeled for 2 h with [35S]methionine, converted to
spheroplasts and lysed. Lysates were centrifuged at 100 000 g, and
2003106 c.p.m. were loaded onto a Superdex-200 gel filtration
column. Fractions were collected and immunoprecipitated with 9E10
ascites fluid (anti-c-myc antibody). The precipitate from fraction 9 is
shown. Polypeptides specific to the complex are indicated by an
asterisk, and the migration of molecular weight standards is indicated
on the left of the panels. Note that c-myc-tagged Bet3p migrates
heterogenously because of the presence of three tags. The same bands
were also observed when the complex was precipitated from
SFNY583, a strain containing c-myc-tagged p18 (not shown). Peptides
obtained from the immunopurified complex are listed in Table I. p18
(Bet5p) was identified as a high-copy suppressor of the bet3-1 mutant
(Jiang et al., 1998). TRAPP subunits co-purify by anion exchange
chromatography. (B) Labeled lysates of SFNY656 were prepared as
above and loaded (503106 c.p.m.) on a Q-Sepharose anion exchange
column. The flow through was collected (lane 3) and the column was
washed with the load buffer (lane 4). The column was washed
subsequently with 0.5 M NaCl (lane 5) and then 1 M NaCl (lane 6).
Fractions were immunoprecipitated with 9E10 ascites fluid as above.
The 9E10 immunoprecipitates from unfractionated labeled lysates of
wild-type (lane 1) and SFNY656 (lane 2) are also shown. Polypeptides
specific to the complex are indicated by an asterisk, and the migration
of molecular weight standards is indicated on the left of the panel.
reading frames (ORFs) predicted proteins of the appropriate molecular weight. The gene encoding p18, BET5
(YML077w), was identified previously as a high-copy
suppressor of the bet3-1 mutant (Jiang et al., 1998). The
only peptides obtained for p31 (Figure 1B, starred band
below p33) were derived from YOR115c, suggesting that
the 31 kDa band may be a breakdown product of p33.
However, we cannot exclude the possibility that p31 is a
distinct, but incompletely resolved, protein. By knowing
the cysteine and methionine content of the smaller subunits, we were able to estimate their stoichiometry by
quantitating the radiolabeled bands shown in Figure 1A
on a phosphoimager. This analysis revealed that these
subunits are present in the complex in approximately
equimolar amounts. All of the identified subunits are
hydrophilic, but none are homologous to known proteins
in the yeast database. The COILS program (Lupas et al.,
1991) predicted that the 33 kDa subunit has potential for
forming a coiled-coil structure at amino acids 20–35, 110–
125 and 195–210.
bands in a complex of ~800 kDa that we call TRAPP
(transport protein particle).
The Bet3p-associated proteins were purified from the
c-myc-tagged strain by precipitating the complex from 1.2
g of lysate. This was achieved by incubating a clarified
detergent extract with affinity-purified immunoglobin
(IgG) that was bound to Affigel. The bound protein was
then eluted at low pH and analyzed by SDS–PAGE. A
control strain that did not contain the tag was treated in
the same way. Bands of the appropriate molecular weight,
which were not observed in the control, were excised
from a Coomassie Blue-stained gel, digested with trypsin
and analyzed by mass spectrometry. The results of this
analysis are presented in Table I.
We found that the low molecular weight bands immunopurified more efficiently than the higher molecular weight
species and, as a consequence, sufficient protein was
obtained to identify the smaller constituents of the complex. The p20 subunit was identified as YBR254c, p23
asYDR246w and p33 as YOR115c. These three open
Like BET5, p20, p23 and p33 are high-copy
suppressors of the bet3-1 mutant
The overexpression of BET5 (p18) was shown previously
to suppress bet3-1, but not other mutants blocked in ERto-Golgi transport (Jiang et al., 1998). A prediction of
these earlier findings is that other subunits of TRAPP may
also act as high-copy suppressors of the temperaturesensitive bet3-1 mutant. To test this hypothesis, we cloned
the genes that encode each of the newly identified subunits
(p20, p23 and p33) into a high-copy vector and tested
their ability to suppress bet3-1. Like BET5, the overexpression of p23 was found to suppress bet3-1 at 30 and 34°C,
while p20 and p33 suppressed this mutant at 30°C (Figure
2A). The growth defect of a temperature-sensitive mutant
in p18 (bet5-1), that blocks transport from the ER to the
Golgi complex (Jiang et al., 1998), was also suppressed
by the overexpression of p33 (our unpublished data). As
was found for BET5, p20, p23 and p33 did not suppress
other ER-accumulating mutants (sec12, sec13, sec16,
sec17, sec18, sec21, sec22, sec23, bos1 and bet1). We
2495
M.Sacher et al.
Fig. 2. The subunits of TRAPP, as well as SED5 or SLY1-20, suppress the growth defect of bet3-1. (A) Yeast cells were grown on a YPD plate and
incubated at 30 and 34°C for 3 days. (B and C) Cells were grown on a YPD plate at 30°C for 3 days. Note: p18, p20, p23, p33 and SED5 are on
2 µm (multicopy) plasmids; SLY1-20 is on a CEN (single-copy) vector. The expression of SED5 is under the control of the TP1 promoter.
conclude that the specific suppression displayed by these
genes is indicative of the fact that they encode components
of the same complex.
Membrane-bound Bet3p resides on the cis-Golgi
complex
When metabolically active yeast spheroplasts were lysed
in a buffer that supports vesicular transport in vitro, most
of the cellular Bet3p was present on membranes (Figure
5D, compare lanes 2–4). To localize membrane-bound
Bet3p, we fused Bet3p to the green fluorescent protein
(GFP) (Prascher et al., 1992; Chalfie et al., 1994). The
Bet3p–GFP fusion protein that we constructed is functional, as it complemented the bet3-1 mutant at 37°C and
supported the growth of yeast cells that lacked the BET3
gene. When we examined wild-type living cells that
contained the Bet3p–GFP fusion protein by confocal
microscopy, brightly stained punctate structures were
found throughout the cytoplasm (Figure 3A). These structures were not visible when the fusion protein was absent
(Figure 3D). Furthermore, GFP alone exhibited a cytoplasmic staining pattern (Figure 3C), indicating that Bet3p
targets the fusion protein to the punctate structures.
The fluorescence pattern of Bet3p–GFP resembles that
of the cis-Golgi marker Sed5p (Banfield et al., 1994) and
2496
not the resident ER protein Kar2p (yeast BiP) (Rose et al.,
1989). Sed5p is found in punctate structures throughout
the cytoplasm (Hardwick and Pelham, 1992), while Kar2p
stains the nuclear envelope and ribbon-like structures at
the cell periphery (see Figure 3E as an example). Attempts
to demonstrate that Bet3p and Sed5p co-localize to the
same compartment by double labeling were hampered as
the usual fixation protocols resulted in a background of
autofluorescence that masked the GFP signal. To show
that Bet3p resides on the Golgi, we took advantage of the
observation that the Golgi forms stacks in sec7 mutant
cells that have been shifted to 37°C in low glucosecontaining medium (Novick et al., 1981). If the
Bet3p–GFP fusion protein resides on the Golgi, the
punctate structures that we observed should become larger
and less numerous in the sec7 shifted cells. Similar
experiments have been used before to show that Ypt1p
resides on the Golgi complex in yeast (Segev et al., 1988;
Brennwald and Novick, 1993). When the Bet3p–GFP
fusion was localized in sec7 mutant cells subsequent to a
2 h incubation at 37°C in YP medium containing 0.1%
glucose, fewer and larger punctate structures were
observed (Figure 3B). At 25°C, these structures were
smaller and more numerous, as in wild-type (not shown).
Thus, Bet3p appears to be associated with the Golgi
Novel complex in ER-to-Golgi transport
Fig. 3. A Bet3p–GFP fusion protein localizes to punctate structures.
The images shown were obtained on a Bio-Rad confocal microscope.
(A) Wild-type cells containing the Bet3p–GFP fusion protein
(SFNY696). (B) sec7-1 mutant cells with the Bet3p–GFP fusion
protein (SFNY710) after a 2 h incubation at 37°C in 0.1% glucose.
(C) Wild-type cells with GFP under the control of the BET3 promoter
(SFNY709). (D) Wild-type cells without the GFP fusion protein.
(E) Wild-type cells with anti-Kar2p antibody.
complex. We also found that sec7-1 mutant cells (Figure
3B) were slightly larger than wild-type (Figure 3A). This
difference is likely to be due to the strain background,
since mutant cells grown at 25°C were also larger.
Subcellular fractionation studies were performed to
determine the subcompartment of the Golgi that contains
Bet3p. In the protocol we employed, a homogenate was
centrifuged to yield P2 (10 000 g pellet) and P3 (100 000 g
pellet) fractions that were then subfractionated on sucrose
step gradients. The location of medial- and trans-Golgi
subcompartments was followed by enzyme assays for
GDPase (Abeijon et al., 1989) and Kex2p (Cunningham
and Wickner, 1989), respectively, while the cis-Golgi
marker Sed5p Banfield et al., 1994) and Bet3p were
monitored on Western blots. Sed5p and Bet3p were
distributed equally between the P2 and P3 fractions, while
most of the GDPase (74 versus 26% in P2) and Kex2p
(67 versus 17% in P2) were found in the P3 fraction.
Bet3p, in the P2 fraction, co-fractionated with Sed5p on
sucrose gradients (Figure 4C) and was clearly separated
from the trans- (Figure 4B) and medial-Golgi markers
(Figure 4A). The same result was obtained when the P3
fraction was subfractionated (not shown). Kex2p was
found in two peaks on these gradients. This result has
been reported before and may represent some overlap
between the medial- and trans-Golgi (Cunningham and
Wickner, 1989).
Fig. 4. Bet3p, present in the P2 fraction, co-fractionates with the cisGolgi marker Sed5p on a 30–50% sucrose step gradient. (A) The cisGolgi (Sed5p) separates from the medial-Golgi (GDPase). (B) The
cis-Golgi (Sed5p) separates from the trans-Golgi (Kex2p). (C) The
t-SNARE Sed5p co-fractionates with Bet3p. GDPase units are
expressed as nmol of phosphate produced per min per fraction. Kex2p
activity is expressed as pmol of 7-amino-4-methyl-coumarin released
per min per fraction. The yields of the maker proteins as well as
Bet3p were estimated from the gradients. Approximately 96% of the
GDPase, 61% of Kex2p, 42% of Bet3p and 75% of the Sed5p loaded
onto the gradient was recovered. The same results were obtained when
the P3 fraction was subfractionated.
Bet3p is required for the targeting/fusion
competence of the Golgi complex
To begin to address the function of TRAPP, we used an
in vitro transport assay that was developed in our laboratory
(Ruohola et al., 1988; Grosech et al., 1990; Lian and
Ferro-Novick, 1993). In this assay, the 26 kDa form of
α-factor marks vesicles that bud from the ER retained
within permeabilized yeast cells (PYCs). The vesicles
formed in vitro do not bind and fuse with post-ER
2497
M.Sacher et al.
membranes retained within the PYCs, instead they are
released from cells to fuse with exogenously added Golgi.
In the Golgi, the 26 kDa form of α-factor is converted to
a heterogeneous high molecular weight product. Conversion to high molecular weight α-factor is measured with
an antibody (anti-outer chain) that specifically recognizes
outer chain carbohydrate which is only added to yeast
glycoproteins in the Golgi complex. In our assay, soluble
factors and Golgi membranes are provided by an S1
fraction (1000 g supernatant). These factors are then
separated during high-speed centrifugation. Resolution of
cytosolic factors (HSS) from Golgi (HSP) and donor
membranes (PYCs) makes it feasible to assess the transport
activities of each of these compartments in vitro.
One way of assessing the function of a protein in vitro
is to test the consequences of depletion. We depleted cells
of Bet3p (Figure 5D, compare lanes 5–8 with lanes 1–4)
by inhibiting its synthesis in a strain (SFNY431) whose
sole copy of BET3 was placed under the control of a
regulatable promoter, and then prepared fractions for
in vitro analysis. Bet3p-depleted cytosol (Figure 5A, lane
2, and 5B, lane 4) or PYCs (not shown) were found to
support all stages of ER-to-Golgi transport, budding
(Figure 5A, lanes 1 and 2) as well as fusion (Figure 5B,
lanes 3 and 4), in an ATP-dependent manner (Figure 5A,
lane 4, and B, lane 1). However, Bet3p-depleted Golgi
failed to support the consumption of vesicles when assayed
in the presence of depleted cytosol (Figure 5B, compare
lane 5 with positive control in lane 3 and negative controls
in lanes 1 and 2), although vesicle budding occurred
normally under these conditions (Figure 5A, lane 3).
Activity was partially restored (Figure 5C, compare lane
1 with 2) when wild-type cytosol, which contains small
amounts of Bet3p (Figure 5D, compare lane 3 with lanes
2 and 4), was incubated with Bet3p-depleted Golgi.
Thus, the depleted acceptor compartment was functional
providing it was supplemented with cytosol that contained
Bet3p. Formal proof that reconstitution was dependent
upon Bet3p will require the addition of purified native
TRAPP.
The overexpression of SED5 and the SLY1-20
mutant suppresses bet3-1 at 30°C
Previous studies have shown that the overexpression of
v-SNAREs (Bos1p/Sec22p), as well as genes that influence
the activity of the v-SNARE (BET1, YPT1), suppresses
bet3-1 (Rossi et al., 1995; Stone et al., 1997). In light of
the localization data and functional studies presented here,
we tested the ability of the t-SNARE gene, SED5, and
a gain-of-function mutant (SLY1-20) in the t-SNAREassociated protein gene SLY1 (Dascher et al., 1991) to
suppress the growth defect of bet3-1. The ability of SEC17
and SEC18 to act as high-copy suppressors of this mutant
was also assessed. This analysis revealed that SED5 and
SLY1-20 suppressed bet3-1 at 30°C (Figure 1B and C),
but not at higher temperatures. Suppression by SED5 was
only observed when this SNARE gene was expressed
under the control of the strong promoter, TP1. In contrast,
SLY1-20 suppressed bet3 when present on a low-copy
CEN plasmid, while the overexpression of SEC17 or
SEC18 failed to suppress this mutant at any temperature.
Thus, BET3 displays genetic interactions with genes that
encode SNAREs, or play a role in assembling the SNARE
2498
Fig. 5. Bet3p is required for the transport activity of the acceptor
Golgi apparatus. (A) Bet3p is dispensable for vesicle budding.
Budding assays were performed in the absence (lanes 1–3) or presence
of apyrase (lane 4). The release of vesicles (marked with pro-α-factor
that is precipitated with Con A–Sepharose) from wild-type PYCs was
assayed in the presence of wild-type cytosol (HSS) and Golgi (HSP)
(lanes 1 and 4), Bet3p-depleted cytosol and wild-type Golgi (lane 2),
and Bet3p-depleted cytosol with Bet3p-depleted Golgi (lane 3). (B)
Transport vesicles fail to be consumed in the absence of Bet3p. This
event was assessed by SDS–gel analysis. Wild-type PYCs were
assayed with wild-type cytosol (HSS) and Golgi (HSP) in the absence
(lane 3) or presence of apyrase (lane 1) or with 7 µg of affinitypurified anti-Bos1p antibody (lane 2). In wild-type, the 26 kDa form
of α-factor (three N-linked oligosaccharides) and a minor species
(24 kDa) with two N-linked oligosaccharide chains was converted to
the high molecular weight product. The remainder of the samples are
as follows: lane 4, Bet3p-depleted cytosol (HSS) and wild-type Golgi
(HSP); lane 5, Bet3p-depleted cytosol (HSS) and Bet3p-depleted Golgi
(HSP). (C) Wild-type cytosol partially restores activity to Bet3pdepleted Golgi. This result is expressed as the percentage maximal
anti-outer chain-precipitable counts of wild-type, where wild-type,
which is shown in lane 3 of (B), is 100%. Lane 1, wild-type PYCs
were assayed with Bet3p-depleted cytosol and Bet3p-depleted Golgi or
with wild-type cytosol and Bet3p-depleted Golgi (lane 2). (D) Western
blot analysis was used to assess the distribution of Bet3p in fractions
assayed for transport. The fractions (200 µg) were as follows: PYCs
(lanes 1 and 5); S1 (lanes 2 and 6); HSS (lanes 3 and 7); and HSP
(lanes 4 and 8). These fractions were prepared from either wild-type
(lanes 1–4) or Bet3p-depleted cells (lanes 5–8) used in the assay. The
distribution of the cis-Golgi marker, Sed5p, was found to be
unchanged in the Bet3p-depleted cells (not shown).
Novel complex in ER-to-Golgi transport
complex at the target membrane (Lian et al., 1994; Søgaard
et al., 1994; Rossi et al., 1995).
The known components of TRAPP are highly
conserved
We reported previously that Bet3p is homologous to a
Caenorhabditis elegans protein of unknown function
(Rossi et al., 1995), suggesting that Bet3p may be highly
conserved. To identify additional homologs of Bet3p, we
performed a BLAST search of the expressed sequence tag
database (dbEST) at the NCBI (National Center for
Biotechnology Information). This search identified a
cDNA sequence (343 bp) from a human placental library
that encodes a peptide (93 codons) which is 47% identical
to a region of Bet3p. The cDNA was amplified by PCR
and used to isolate a full-length clone from the same human
placental cDNA library. Seven clones were obtained, six
of which were ~1.3 kb in length, while the seventh was
2.5 kb. DNA sequence analysis indicated that six of the
clones were derived from a common mRNA. The seventh
clone was the product of unspliced mRNA that was reverse
transcribed during the construction of the library. The 1.3
kb cDNA encoded an ORF of 180 codons (DDBJ/EMBL/
GenBank accession No. AJ224335) that was 54% identical
and 72% similar in overall sequence to yeast Bet3p
(Figure 6C).
A search of dbEST using yeast p20, p23 and p33
revealed multiple sequences from human and murine
sources with homologies to the yeast proteins. Contiguous
EST sequences were assembled, and full-length human
homologs were identified for p20 (Figure 6A), p23 (Figure
6B) and p33 (Figure 6D). Identities between these mammalian and yeast subunits ranged from 31.8 to 41% and
similarities ranged from 41.1 to 57% (see legend to Figure
6). A human homolog of BET5 (p18) which is 29%
identical and 53.8% similar to the yeast protein has been
reported previously (Jiang et al., 1998). The extremely
high evolutionary conservation between the yeast and
mammalian subunits indicates that TRAPP plays a critical
role in the secretory pathway in both yeast and man.
Discussion
Several lines of evidence implicate TRAPP as a key
player in the late stages of ER-to-Golgi transport.
Fluorescence studies and subcellular fractionation experiments indicate that Bet3p resides on the Golgi and colocalizes with the t-SNARE Sed5p, a cis-Golgi marker.
2499
M.Sacher et al.
The association of Bet3p with the cis-Golgi is in accord
with the notion that TRAPP may target vesicles to this
membrane. This proposal is corroborated by in vitro
findings demonstrating that Bet3p is required for vesicle
targeting and fusion, but not budding. Bet3p appears to
function on the Golgi, as the loss of Bet3p activity
from otherwise functional Golgi membranes specifically
abolishes the transport competence of this compartment
in vitro. Finally, the known components of TRAPP are
highly conserved, and antibodies to the human homolog
of Bet3p have shown that this protein is in a large
complex that is similar in size to yeast TRAPP
(J.Barrowman and S.Ferro-Novick, unpublished data).
Previous studies have demonstrated that the overexpr-
ession of v-SNAREs (Bos1p/Sec22p), as well as genes
that influence the activity of the v-SNARE (BET1,
YPT1), suppress bet3-1 (Rossi et al., 1995; Stone et al.,
1997). Here, we show (Figure 2B and C) that the tSNARE gene, SED5, and a gain-of-function mutant
(SLY1-20) in the t-SNARE-associated protein gene SLY1
suppress the growth defect of bet3-1. Taken together,
these genetic findings indicate that Bet3p acts upstream
of the SNAREs. Consistent with this proposal is the
finding that the SNARE complex fails to form at 37°C
in bet3-1 (Rossi et al., 1995) and bet5-1 (J.Burston and
S.Ferro-Novick, unpublished data) mutant cells.
Many of the genes that suppress bet3-1 (Rossi et al.,
1995; Figure 2B and C) and bet5-1 (Jiang et al., 1998)
Fig. 6. Yeast TRAPP subunits are highly conserved in mammalian cells. A BLAST search of dbEST was performed with the p20, p23, Bet3p and
p33 subunits of TRAPP. Contiguous EST sequences were assembled to give full-length human or murine sequences for p20, p23 and p33. Human
Bet3 protein was cloned as described in Materials and methods. TRAPP subunits were aligned with their respective mammalian homologs using
MegAlign, and values for percentage identity and similarity were calculated using GAP software from the Wisconsin Genetics Computer Group
(version 8.1). Identical residues are shaded in black while similarities are shaded in gray. The position of the stop codon in each sequence is marked
with a full point. (A) Yeast p20 aligned with human p20 (41% identity/57% similarity). (B) Yeast p23 aligned with human p23 (33.5% identity/
43.8% similarity). (C) Yeast Bet3p aligned with human Bet3p (54% identity/63% similarity). (D) Yeast p33 aligned with human p33 (33.5% identity/
47.1% similarity). Note that X in the figure represents an unknown amino acid due to sequence ambiguity.
2500
Novel complex in ER-to-Golgi transport
also suppress the temperature-sensitive uso1-1 mutant
(Sapperstein et al., 1996). Uso1p, which is larger than
any of the subunits of TRAPP (206 kDa), is a
cytoplasmic factor that may tether transport vesicles to
the Golgi apparatus (Nakajima et al., 1991; Barlowe,
1997). Like TRAPP, it acts prior to SNARE complex
assembly (Sapperstein et al., 1996). Therefore, TRAPP
and Uso1p may function together to mediate a common
step in ER-to-Golgi transport. In support of this
hypothesis is the recent finding that the overexpression
of USO1 suppresses the growth defect of the bet5-1
mutant (Jiang et al., 1998). Since Uso1p is soluble, it
may interact with proteins on the transport vesicle as
well as a specific factor or complex on the cis-Golgi,
such as TRAPP. As a receptor for Uso1p, TRAPP may
play a role in directing or trapping transport vesicles to
specific sites on the acceptor compartment. Alternatively,
Uso1p and TRAPP may each act independently to target
vesicles to the cis-Golgi apparatus. Experiments currently
in progress should enable us to address these possibilities.
Earlier studies on BET3 suggested a role for its
product at multiple stages of the secretory pathway.
This hypothesis was based largely on the fact that
bet3-1 displays synthetic lethal interactions with certain
late-acting sec mutants (i.e. sec2 and sec4) that are
blocked in membrane traffic from the Golgi to the cell
surface (Rossi et al., 1995). Recent observations,
however, have led us to conclude that these synthetic
lethal interactions do not reflect an involvement of
Bet3p in post-Golgi secretion. Fluorescence studies
have shown that membrane-bound Bet3p is associated
exclusively with punctate structures and not with the
plasma membrane. In addition, the overexpression of
SEC2 or SEC4 (as well as of SEC8 and SEC15) cannot
suppress the growth defect of the bet3-1 mutant (our
unpublished observations), while a number of genes
whose products are required for ER-to-Golgi transport
can perform this function (Rossi et al., 1995; Figure
2B and C). Thus, as Bet3p acts at the Golgi, the
combination of the bet3-1 mutation with certain postGolgi secretory mutations may aggravate defects in
membrane traffic indirectly and lead to cell death. This
situation may be comparable with the endocytic/vacuolar
transport pathways where genes whose products act in
different processes on the same pathway display synthetic
lethal interactions with each other (Singer-Krüger and
Ferro-Novick, 1997).
While members of the ER-to-Golgi SNARE complex
are homologous to their counterparts in other transport
events (Ferro-Novick and Jahn, 1994), the five known
constituents of TRAPP do not share sequence similarity
with other components of the secretory apparatus,
including the exocyst, a multiprotein complex thought
to be required exclusively for post-Golgi secretion in
yeast and mammalian cells (Hsu et al., 1996; TerBush
et al., 1996; Guo et al., 1997). The exocyst has been
implicated in the targeting of secretory vesicles to the
tips of small buds where membrane fusion takes place
(TerBush and Novick, 1995). Analogs that function at
other stages of the secretory pathway have not been
found. We hypothesize that the SNAREs are homologous
to each other because the mechanism of endoplasmic
membrane fusion is highly conserved at each transport
step. However, a putative component of the vesicle
targeting machinery that specifically recognizes and
binds to only one type of vesicle may not resemble
other vesicle targeting receptors that act at a different
stage of membrane traffic. Further purification of TRAPP
will lead to the identification of the other subunits and,
in combination with functional studies, will enable us
to probe its proposed role in the targeting of vesicles
to the Golgi apparatus.
Materials and methods
Construction of a yeast strain containing epitope-tagged
BET3
To construct triple c-myc-tagged Bet3p, two c-myc epitopes were inserted
by site-directed mutagenesis into plasmid pGR15 (Rossi et al., 1995) to
yield a protein with the following C-terminus: IGEDAEQKLISEEDLAEQKLISEEDLAEQKLISEEDLA. After confirming that the mutagenesis
was correct by DNA sequence analysis, this construct was used to
replace the wild-type BET3 gene in SFNY26-3A by the pop-in/pop-out
method (Guthrie and Fink, 1991). Yeast containing triple-tagged Bet3p
as the sole copy of BET3 (SFNY656) showed the same growth properties
as wild-type.
In vivo labeling and immunoprecipitations
For c-myc precipitations, 30 U of cells at OD599, radiolabeled in 15 ml
with 100 µCi of ProMix/ml for 2 h at 25°C, were converted to
spheroplasts and lysed in 0.6 ml of lysis buffer [20 mM HEPES (pH
7.2), 150 mM KCl, 0.5 mM dithiothreitol (DTT), 2 mM EDTA, 13
protein inhibitor cocktail (PIC)]. The cell lysate was centrifuged at 100
000 g for 1 h, and the radiolabeled supernatant was diluted with buffer
A (20 mM HEPES pH 7.4, 150 mM KCl, 0.5 mM DTT, 2 mM EDTA,
0.5% Triton X-100 and 13 PIC; Ruohola et al., 1988) to 503106 c.p.m./
ml. The supernatant was pre-cleared during a 1 h incubation with protein
A–Sepharose beads and then the sample was transferred to a new tube
containing 2 µl of 9E10 (anti-c-myc epitope) ascites fluid. The antigen–
antibody complexes that formed during a 2 h incubation (or overnight)
at 4°C were precipitated onto protein A–Sepharose beads (1 h at 4°C).
The beads were washed three times with buffer B (20 mM HEPES pH
7.4, 500 mM KCl, 0.5 mM DTT, 2 mM EDTA, 0.5% Triton X-100, 13
PIC) and three times with buffer A. After the final wash, the samples
were heated in sample buffer and analyzed on a 13% SDS–polyacrylamide
gel. To immunoprecipitate the membrane-bound form of the complex,
the 100 000 g pellet (described above) was extracted with 2% Triton
X-100 and then centrifuged at 100 000 g for 30 min. The resulting
supernatant was immunoprecipitated as above. The soluble and membrane-bound forms of the complex appeared to contain the same
constituents.
Purification of TRAPP
SFNY656 (myc Bet3p) and SFNY26-3A (wild-type) were converted to
spheroplasts, lysed in buffer C (20 mM HEPES pH 7.4, 150 mM KCl,
0.5 mM DTT, 2 mM EDTA, 2% Triton X-100 and 13 PIC) and
centrifuged at 100 000 g for 1 h. The high-speed supernatant (1.2 g)
was incubated for 1 h with 1.5 ml of bed volume of Affigel 10 beads
coupled to 20 mg of purified anti-c-myc IgG. The beads were loaded
into a glass column and washed with 10 bed volumes of buffer A and
five bed volumes of buffer B. Bound protein was eluted with two bed
volumes of 0.2 M glycine (pH 2.8), precipitated with 10% trichloroacetic
acid, and resolved on a 12.5% SDS–polyacrylamide gel. The Coomassie
Blue-stained bands specific to the SFNY656 lysate were excised and
subjected to trypsin digestion. The resulting peptides were identified
using microelectrospray LC tandem mass spectrometry, and the tandem
mass spectra were matched to their respective amino acid sequences in
the yeast protein sequence database as described below.
Microelectrospray high performance liquid chromatography
Microelectrospray columns were constructed from 360 µm
o.d.3100 µm i.d. fused silica capillary with the column tip tapered to a
5–10 µm opening. The columns were packed with Perseptive Biosystems
(Framingham, MA) POROS 10 R2, a 10 mm reversed-phase packing
material, to a length of 10–12 cm. The flow through the column was
split pre-column to achieve a flow rate of 150 nl/min. Typically, the
flow from the HPLC pumps was 150 nl/min. The mobile phase used for
2501
M.Sacher et al.
gradient elution consisted of (A) 0.5% acetic acid and (B) acetonitrile/
water 80:20 (v/v) containing 0.5% acetic acid. The gradient was linear
from 0 to 40% B in 50 min followed by 40–80% B in 10 min or 0–
60% B in 30 min. Mass spectra were recorded on a TSQ700 (Finnigan
MAT, San Jose, CA) equipped with an electrospray ionization source.
Electrospray was performed by setting the needle voltage at 1.6 kV.
Tandem mass spectra were acquired using an Instrument Control Language (ICL) as described previously (McCormack et al., 1997).
Database searching
Amino acid sequence databases were searched directly with tandem
mass spectra using the computer algorithm, SEQUEST, described previously (Eng et al., 1994; Yates et al., 1995). The S.cerevisiae sequence
database (7499 entries) was obtained from the Stanford yeast sequencing
project (http://genome-stanford.edu/). Sequences for potential contaminants such as human keratin and bovine trypsin are added to the database.
Fluorescence
A Bet3p–GFP fusion was constructed in several steps. First, using
PCR, the first 10 bases from the 39-untranslated region of BET3 were
fused behind the stop codon of GFP. Second, using PCR extension,
this engineered GFP gene was used to replace the stop codon of
BET3. Finally, a 1.34 kb HindIII fragment containing the BET3–GFP
fusion was inserted into plasmid pSFN515 (CEN, LEU2) subsequent
to the removal of a 0.63 kb HindIII–HindIII fragment that contains
the BET3 gene. The resulting plasmid (pSFN516) was then transformed
into a diploid strain in which one copy of BET3 was disrupted by
URA3. The diploid strain was sporulated and tetrad analysis was
performed. A Leu1, Ura1 haploid colony (SFNY696) was used in
the fluorescence studies. A sec7 strain containing the fusion protein
was constructed by crossing SFNY696 to the sec7-1 mutant and then
performing tetrad analysis. A Leu1, Ura1 colony that was temperaturesensitive for growth was selected for the experiment shown in Figure
3. For fluorescence studies, yeast cells were grown to early log phase
and then directly examined on a Bio-Rad confocal microscope.
Subcellular fractionation and enzyme assays
Subcellular fractionation was performed as before (Newman et al.,
1992) with 600 units of cells (SFNY26-3A) at OD599, which were
converted to spheroplasts and lysed in 8 ml of lysis buffer (20 mM
triethanolamine pH 7.2, 1 mM EDTA, 0.8 M sorbitol). The unbroken
cells (P1) were separated from the lysate during centrifugation at 450
g for 3 min. The resulting S1 fraction was then centrifuged at 10
000 g for 10 min to generate pellet (P2) and supernatant (S2)
fractions. The P3 (pellet) and S3 (supernatant) fractions were prepared
by centrifuging the S2 fraction for 1 h at 100 000 g, and then
sucrose density fractionation was performed on the P2 and P3
fractions. Each fraction was homogenized in 55% (w/w) sucrose that
was buffered with 20 mM HEPES (pH 7.2) and then placed at the
bottom of a 12 ml Beckman polyallomer tube (14389 mm). Sucrose
solutions (w/w) buffered with 20 mM HEPES (pH 7.2) were layered
as follows: 1 ml 50%, 1 ml 47.5%, 1.5 ml 45%, 1.5 ml 42%, 1.5
ml 40%, 1 ml 37.5%, 1 ml 35% and 1 ml 30%. The samples were
centrifuged in an SW41 rotor for 16 h at 170 000 g and 0.5 ml
fractions were collected from the top of the gradient. GDPase (Abeijon
et al., 1989) and Kex2p assays (Cunningham and Wickner, 1989)
were performed as described previously, and Sed5p as well as Bet3p
were localized by Western blot analysis using the ECL method
(Amersham).
In vitro transport assay and preparation of fractions
To deplete cells of Bet3p, SFNY431 [MATa, Gal1, ura3-52, leu2-3,
112, bet3∆::URA3, pGR10 (GAL1-BET3, LEU2)] was grown to
stationary phase in YP medium with 2% raffinose and 0.5% galactose
and then diluted to an OD599 5 0.01 into YP medium containing
2% glucose. After 11 h, the cells were harvested and fractions were
prepared for the transport assay. The assay, and the preparation of
fractions, was performed as described previously (Ruohola et al.,
1988; Groesch et al., 1990; Lian and Ferro-Novick, 1993).
Cloning the human homolog of BET3
Using the Bet3p sequence, a BLAST search of the dbEST database
(Altschul et al., 1990) yielded a match with an EST from a human
placental cDNA library (Stratagene). This partial cDNA was amplified
by PCR using the following primer set (59 to 39): sense primer GGC
ACC GAG AGC AAG AAA ATG AGC; antisense primer CCC
AAG TAC ATC TTG AAC GCC ACC. The PCR products were
2502
then used as a probe to screen ~450 000 bacteriophage plaques from
a Clontech human placental library (catalog # HL5014) by the
protocol supplied by the manufacturer. Through three or four rounds
of subsequent purification, seven clones were purified until all plaques
on the plate were positive. Restriction enzyme digestion indicated
that six of the clones contained inserts of 1.3 kb, while the seventh
had a 2.5 kb insert that was found to be the product of reversetranscribed unspliced mRNA. Plasmid clones were sequenced at the
Keck Foundation at Yale University. Sequence analysis and the
database searches were performed using the Wisconsin Genetics
Computer Group (GCG) software version 8.1.
Accession number
The nucleotide sequence data for human bet3 will appear in the
DDBJ/EMBL/GenBank and nucleotide sequence database under the
accession No. AJ224335.
Acknowledgements
We thank Dr Tom Hughes for his advice on the use of GFP and
the hours he spent in helping us obtain images of fluorescent yeast
on the confocal microscope, Anne Marie Quinn for DNA sequence
analysis and Joyce Anguillare for her help in the preparation of this
manuscript. We also thank Drs Chavela Carr and Ruth Collins for
their comments on the manuscript, and Drs Hugh Pelham, Mark Rose
and Hans Dieter Schmitt for antibodies and plasmids. M.S. is
supported as an Associate of the Howard Hughes Medical Institute.
H.A. was supported as an Associate of the Howard Hughes Medical
Institute and is a postdoctoral fellow of the Human Frontiers Science
Foundation.
References
Abeijon,C., Orlean,P., Robbins,P.W. and Hirshberg,C.B. (1989)
Topography of glycosylation in yeast: characterization of
GDPmannose transport and lumenal guanosine diphosphatase
activities in Golgi-like vesicles. Proc. Natl Acad. Sci. USA, 86,
6935–6939.
Altschul,S.F., Gish,W., Miller,W., Myers,E.W. and Lipman,D.J. (1990)
Basic local alignment search tool. J. Mol. Biol., 215, 403–410.
Banfield,D.K., Lewis,M.J., Rabouille,C., Warren,G. and Pelham,H.R.B.
(1994) Localization of Sed5, a putative vesicle targeting molecule,
to the cis-Golgi network involves both its transmembrane and
cytoplasmic domains. J. Cell Biol., 127, 357–371.
Barlowe,C. (1997) Coupled ER to Golgi transport reconstituted with
purified cytosolic proteins. J. Cell Biol. 139, 1097–1108.
Brennwald,P. and Novick,P. (1993) Interactions of three domains
distinguishing the Ras-related GTP-binding proteins Ypt1 and Sec4.
Nature, 362, 560–563.
Chalfie,M., Tu,Y., Euskirchen,G., Ward,W.W. and Prascher,D.C. (1994)
Green fluorescent protein as a marker for gene expression. Science,
263, 802–805.
Cunningham,K.W. and Wickner,W.T. (1989) Yeast KEX2 protease and
mannosyltransferase I are localized to distinct compartments of the
secretory pathway. Yeast, 5, 25–33.
Dascher,C., Ossig,R., Gallwitz,D. and Schmitt,H.D. (1991)
Identification and structure of four yeast genes (SLY) that are able
to suppress the functional loss of YPT1, a member of the RAS
superfamily. Mol. Cell Biol., 11, 872–885.
Eng,J.K., McCormack,A.L. and Yates,J.R.,III (1994) An approach to
correlate MS/MS data to amino acid sequences in a protein
database. J. Am. Soc. Mass Spectrom., 5, 976–989.
Ferro-Novick,S. and Jahn,R. (1994) Vesicle fusion from yeast to man.
Nature, 370, 191–193.
Fischer von Mollard,G., Nothwehr,F.S. and Stevens,T.H. (1997) The
yeast v-SNARE Vti1p mediates two vesicle transport pathways
through interactions with the t-SNAREs Sed5p and Pepl2p. J. Cell
Biol., 137, 1511–1524.
Griff,I.C., Schekman,R., Rothman,J.E. and Kaiser,C.A. (1992) The
yeast SEC17 gene product is functionally equivalent to mammalian
α-SNAP. J. Biol. Chem,. 267, 12106–12115.
Novel complex in ER-to-Golgi transport
Groesch,M., Ruohola,H., Bacon,R., Rossi,G. and Ferro-Novick,S.
(1990) Isolation of a functional vesicular intermediate that mediates
ER to Golgi transport in yeast. J. Cell Biol., 111, 45–53.
Guo,W., Roth,D., Gatti,E., De Camilli,P. and Novick,P. (1997)
Identification and characterization of homologues of the exocyst
component Sec10p. FEBS Lett., 404, 135–139.
Guthrie,C. and Fink,G. (1991) Guide to Yeast Genetics and Molecular
Biology. Academic Press, pp. 281–301.
Hardwick,K.G. and Pelham,H.R. (1992) SED5 encodes a 39-kD
integral membrane protein required for vesicular transport between
the ER and the Golgi complex. J. Cell Biol., 119, 513–521.
Hsu,S.-C., Ting,A.E., Hazuka,C.D., Davanger,S., Kenny,J.W., Kee,J.
and Scheller,R.H. (1996) The mammalian brain rsec6/8 complex.
Neuron, 17, 1209–1219.
Jiang,Y., Scarpa,A., Zhang,L., Stone,S., Feliciano,E. and FerroNovick,S. (1998) A high copy suppressor screen reveals genetic
interactions between BET3 and a new gene: evidence for a novel
complex in ER to Golgi transport. Genetics, in press.
Lian,J.P. and Ferro-Novick,S. (1993) Bos1p, an integral membrane
protein of the endoplasmic reticulum to Golgi transport vesicles,
is required for their fusion competence. Cell, 73, 735–745.
Lian,J.P., StoneS., Jiang,Y., Lyons,P. and Ferro-Novick,S. (1994) Ypt1p
implicated in v-SNARE activation. Nature, 372, 698–701.
Lupas,A., Van Dyke,M. and Stock,J. (1991) Predicting coiled coils
from protein sequences. Science, 252, 1162–1164.
Mayer,A., Wickner,W. and Haas,A. (1996) Sec18p (NSF)-driven
release of Sec17p (α-SNAP) can precede docking and fusion of
yeast vacuoles. Cell, 85, 83–94.
McCormack,A.L., Schieltz,D.M., Goode,B., Yang,S., Barnes,G.,
Drubin,D. and Yates,J.R.,III (1997) Direct analysis and identification
of proteins in mixtures by LC/MS/MS and database searching at
the low femtomole level. Anal. Chem., 69, 767–776.
Nakajima,H., Hirata,A., Ogawa,Y., Yonehara,T., Yoda,K. and
Yamasaki,M. (1991) A cytoskeleton-related gene, USO1, is required
for intracellular protein transport in Saccharomyces cerevisiae. J.
Cell Biol., 113, 245–260.
Newman,A.P., Groesch,M.E. and Ferro-Novick,S. (1992) Bos1p, a
membrane protein required for ER to Golgi transport in yeast, copurifies with the carrier vesicles and with Bet1p and the ER
membrane. EMBO J., 11, 3609–3617.
Novick,P., Ferro,S. and Schekman,R. (1981) Order of events in the
yeast secretory pathway. Cell, 25, 461–469.
Prasher,D.C., Eckenrode,V.K., Ward,W.W., Prendergast,F.G. and
Cormier,M.J. (1992) Primary structure of the Aequorea victoria
green-fluorescent protein. Gene, 11, 229–233.
Rose,M.D., Misra,L.M. and Vogel,J.P. (1989) KAR2, a karyogamy
gene is the yeast homolog of the mammalian BiP/GRP78 gene.
Cell, 57, 1211–1221.
Rossi,G., Kolstad,K., Stone,S., Palluault,F. and Ferro-Novick,S. (1995)
BET3 encodes a novel hydrophilic protein that acts in conjunction
with yeast SNAREs. Mol. Biol. Cell, 6, 1769–1780.
Ruohola,H., Kabcenell,A.K. and Ferro-Novick,S. (1988) Reconstitution
of protein transport from the endoplasmic reticulum to the Golgi
complex in yeast: the accceptor Golgi compartment is defective in
the sec23 mutant. J. Cell Biol., 107, 1465–1476.
Sacher,M., Stone,S. and Ferro-Novick,S. (1997) The synaptobrevinrelated domains of Bos1p and Sec22p bind to the syntaxin-like
region of Sed5p. J. Biol. Chem., 272, 17134–17138.
Sapperstein,S.K., Lupashin,V.V., Schmitt,H.D. and Waters,M.G. (1996)
Assembly of the ER to Golgi SNARE complex requires Usolp.
J. Cell Biol., 132, 755–767.
Segev,N., Mulholland,J. and Botstein,D. (1988) The yeast GTPbinding YPT1 protein and a mammalian counterpart are associated
with the secretion machinery. Cell, 52, 915–924.
Singer-Krüger,B. and Ferro-Novick,S. (1997) Use of a synthetic lethal
screen to identify yeast mutants impaired in endocytosis, vacuolar
protein sorting and the organization of the actin cytoskeleton. Eur.
J. Cell Biol., 74, 365–375.
Søgaard,M., Tani,K., Ye,R.R., Geromanos,S., Tempst,P., Kirchhausen,T.,
Rothman,J.E. and Söllner,T. (1994) A rab protein is required for
the assembly of SNARE complexes in the docking of transport
vesicles. Cell, 78, 937–948.
Söllner,T., Whiteheart,S.W., Brunner,M., Erdjument-Bromage,H.,
Geromanos,S., Tempst,P. and Rothman,J.E. (1993a) SNAP receptors
implicated in vesicle targeting and fusion. Nature, 362, 318–324.
Söllner,T., Bennett,M.K., Whiteheart,S.W., Scheller,R.H. and
Rothman,J.E. (1993b) A protein assembly–disassembly pathway
in vitro that may correspond to sequential steps of synaptic vesicle
docking, activation, and fusion. Cell, 75, 409–418.
Stone,S., Sacher,M., Mao,Y., Carr,C., Lyons,P., Quinn,A.M. and FerroNovick,S. (1997) Bet1p activates the v-SNARE, Bos1p. Mol. Biol.
Cell, 8, 1175–1181.
TerBush,D.R. and Novick,P. (1995) Sec6, Sec8, and Sec15 are
components of a multisubunit complex which localizes to small
bud tips in Saccharomyces cerevisiae. J. Cell Biol., 130, 299–312.
TerBush,D.R., Maurice,T., Roth,D. and Novick,P. (1996) The exocyst
is a multiprotein complex required for exocytosis in Saccharomyces
cerevisae. EMBO J., 15, 6483–6494.
Wilson,D.W., Wilcox,C.A., Flynn,G.C., Chen,E., Kuang,W.-J.,
Henzel,.J., Block,M.R., Ullrich,A. and Rothman,J.E. (1989) A fusion
protein required for vesicle-mediated transport in both mammalian
cells and yeast. Nature, 339, 355–359.
Yates,J.R.,III, Eng,J.K., McCormack,A.L. and Schieltz,D. (1995) A
method to correlate tandem mass spectra of modified peptides to
amino acid sequences in the protein database. Anal. Chem., 67,
1426–1436.
Received January 15, 1998; revised and accepted February 27, 1998
2503
View publication stats